On Monday, GeneDx Holdings Corp (NASDAQ: WGS) was 3.59% up from the session before settling in for the closing price of $64.57. A 52-week range for WGS has been $24.91 – $117.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 14.24%. When this article was written, the company’s average yearly earnings per share was at 319.52%. With a float of $24.97 million, this company’s outstanding shares have now reached $28.53 million.
Considering the fact that the conglomerate employs 1000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 63.93%, operating margin of -4.2%, and the pretax margin is -11.62%.
GeneDx Holdings Corp (WGS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GeneDx Holdings Corp stocks. The insider ownership of GeneDx Holdings Corp is 12.50%, while institutional ownership is 101.86%. The most recent insider transaction that took place on Jun 09 ’25, was worth 91,848. In this transaction CHIEF FINANCIAL OFFICER of this company sold 1,266 shares at a rate of $72.55, taking the stock ownership to the 5,301 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Chief Executive Officer sold 3,639 for $72.55, making the entire transaction worth $264,009. This insider now owns 6,348 shares in total.
GeneDx Holdings Corp (WGS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 319.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 120.75% during the next five years compared to 96.65% growth over the previous five years of trading.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
You can see what GeneDx Holdings Corp (WGS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 2.03 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Compared to the last year’s volume of 1.11 million, its volume of 0.76 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 21.15%. Additionally, its Average True Range was 4.79.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 18.72%, which indicates a significant decrease from 27.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.44% in the past 14 days, which was lower than the 133.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $77.79, while its 200-day Moving Average is $73.26. Nevertheless, the first resistance level for the watch stands at $68.02 in the near term. At $69.16, the stock is likely to face the second major resistance level. The third major resistance level sits at $71.37. If the price goes on to break the first support level at $64.67, it is likely to go to the next support level at $62.46. Should the price break the second support level, the third support level stands at $61.32.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
There are 28,533K outstanding shares of the company, which has a market capitalization of 1.91 billion. As of now, sales total 305,450 K while income totals -52,290 K. Its latest quarter income was 87,120 K while its last quarter net income were -6,530 K.
